Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Abdo

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical and Translational Gastroenterology|October 24, 2025
Assessing Risk of Progression in Barrett's Esophagus Using a Mass-Spectrometry-Based Proteomic PanelAndrew Cannon, Rofyda Elhalaby, Igor Ban, et al.
Frontiers in Oncology|April 30, 2019
Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer SpecimenJoe Abdo, Christopher S Wichman, Nicholas E Dietz, et al.
Frontiers in Oncology|June 6, 2018
Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer SpecimenJoe Abdo, Christopher S Wichman, Nicholas E Dietz, et al.
Cancers|September 13, 2025
Clinical Utility of the EpiSwitch CiRT Test to Guide Immunotherapy Across Solid Tumors: Interim Results from the PROWES StudyJoe Abdo, Joos Berghausen, Ryan Mathis, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature reviewSumeet K Mittal, Joe Abdo, Malika P Adrien, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical and Translational Gastroenterology|October 24, 2025
Assessing Risk of Progression in Barrett's Esophagus Using a Mass-Spectrometry-Based Proteomic PanelAndrew Cannon, Rofyda Elhalaby, Igor Ban, et al.
Frontiers in Oncology|April 30, 2019
Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer SpecimenJoe Abdo, Christopher S Wichman, Nicholas E Dietz, et al.
Frontiers in Oncology|June 6, 2018
Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer SpecimenJoe Abdo, Christopher S Wichman, Nicholas E Dietz, et al.
Cancers|September 13, 2025
Clinical Utility of the EpiSwitch CiRT Test to Guide Immunotherapy Across Solid Tumors: Interim Results from the PROWES StudyJoe Abdo, Joos Berghausen, Ryan Mathis, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature reviewSumeet K Mittal, Joe Abdo, Malika P Adrien, et al.
Pageof 2